The U.S. government is asking a federal district court in Washington, D.C., to rule for drugmakers in four separate lawsuits [...] Read More »
Category: Pharma Industry
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...] Read More »
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Pharmaceutical manufacturer Merck has announced it will refund 340B covered entities for certain overcharges of its inhaler, Proventil HFA, during [...] Read More »
Please Login or Become a Paid Subscriber to View this Content
If you are already a
The new industry vendor administrating Johnson & Johnson’s (J&J’s) contested 340B rebate proposal is hosting an in-person training for third [...] Read More »
Please Login or Become a Paid Subscriber to View this Content
If you are already a
German drugmaker Bayer will no longer exempt federal grantees from its 340B contract pharmacy policy beginning Oct. 1—the same day [...] Read More »
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Johnson & Johnson (J&J) has ended its contract pharmacy restrictions for covered entities in Arkansas, making the New Jersey-based pharmaceutical [...] Read More »
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Certain formulations for four of the first ten drugs selected for Medicare drug price negotiations have newly negotiated prices lower [...] Read More »
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A Boston-based biopharmaceutical company will soon extend its contract pharmacy restrictions from hospitals to all 340B covered entities (CEs), except [...] Read More »
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Two major hospital advocacy groups are urging the federal agency that oversees the 340B program to “take immediate enforcement action” [...] Read More »
Please Login or Become a Paid Subscriber to View this Content
If you are already a
The 340B program’s growth in recent decades has helped it attract a growing number of corporate and private equity investments, [...] Read More »